Steven Charles Nelson net worth and biography

Steven Nelson Biography and Net Worth

Chief Commercial Office of DarioHealth

Steven is instrumental in developing and executing strategies to drive rapid commercialization. Nelson oversees Dario’s global commercial activites, including growth strategy, sales, client management, marketing, strategic partnerships, and expansion into new markets. Steven brings over two decades of experience building and scaling technology-centric healthcare companies. Most recently, Nelson served as the Chief Executive Officer and President of Contigo Health, a multi-faceted collaborator for healthcare providers, plans, and employers. During his tenure at Contigo Health, he led the company to revenue scale and turned the business to profitability, managed over 75 clients in the portfolio, and established several national and regional health plan partnerships as well as employer relationships. Before his role at Contigo, Nelson served as the Chief Operating Officer of Anthem Inc.’s Diversified Business Group. There, he played a pivotal role in the “One Anthem” transformation initiative that developed strategic business plans resulting in a $7 billion run-rate revenue.

What is Steven Charles Nelson's net worth?: The estimated net worth of Steven Charles Nelson is at least $33.45 thousand as of August 27th, 2025. Mr. Nelson owns 4,750 shares of DarioHealth stock worth more than $33,454 as of September 22nd. This net worth estimate does not reflect any other investments that Mr. Nelson may own. Learn More about Steven Charles Nelson's net worth.
How do I contact Steven Charles Nelson?: The corporate mailing address for Mr. Nelson and other DarioHealth executives is 322 W 57th ST. #33b, New York, NY, 10019. DarioHealth can also be reached via phone at +97247706377 and via email at [email protected]. Learn More on Steven Charles Nelson's contact information.
Has Steven Charles Nelson been buying or selling shares of DarioHealth?: Steven Charles Nelson has not been actively trading shares of DarioHealth in the last ninety days. Most recently, on Wednesday, September 11th, Steven Charles Nelson bought 250 shares of DarioHealth stock. The stock was acquired at an average cost of $16.00 per share, with a total value of $4,000.00. Following the completion of the transaction, the insider now directly owns 2,500 shares of the company's stock, valued at $40,000. Learn More on Steven Charles Nelson's trading history.
Who are DarioHealth's active insiders?: DarioHealth's insider roster includes Dror Bacher (COO), Oded Cohen (Insider), Dennis Matheis (Director), Dennis McGrath (Director), Steven Nelson (Chief Commercial Office), and Erez Raphael (CEO). Learn More on DarioHealth's active insiders.
Are insiders buying or selling shares of DarioHealth?: In the last year, DarioHealth insiders bought shares 1 times. They purchased a total of 14,430 shares worth more than $99,999.90. The most recent insider tranaction occured on July, 23rd when Director Dennis Matheis bought 14,430 shares worth more than $99,999.90. Insiders at DarioHealth own 3.5% of the company. Learn More about insider trades at DarioHealth.
Information on this page was last updated on 7/23/2026.

Steven Charles Nelson Insider Trading History at DarioHealth

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2024	Buy	250	$16.00	$4,000.00	2,500
9/9/2024	Buy	250	$16.00	$4,000.00	2,000
9/5/2024	Buy	250	$16.40	$4,100.00	1,500

Steven Charles Nelson Buying and Selling Activity at DarioHealth

DarioHealth Company Overview

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Today's Range

Now: $6.99

$6.95

$7.13

50 Day Range

MA: $7.17

$6.53

$7.90

2 Week Range

Now: $6.99

$5.84

$17.74

Volume

30,143 shs

Average Volume

28,214 shs

Market Capitalization

$68.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12